155 related articles for article (PubMed ID: 35463661)
1. Analysis of Multiple Vitamins Serum Levels and Disease-Related Factors in Children with Acute Leukemia.
Song Z; Li J; Cao J; Zhang L; Zhang Z; Feng S; Zhong D; Yue M; Hu M; Liu R
J Healthc Eng; 2022; 2022():5330563. PubMed ID: 35463661
[TBL] [Abstract][Full Text] [Related]
2. Extended intrathecal methotrexate may replace cranial irradiation for prevention of CNS relapse in children with intermediate-risk acute lymphoblastic leukemia treated with Berlin-Frankfurt-Münster-based intensive chemotherapy. The Associazione Italiana di Ematologia ed Oncologia Pediatrica.
Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi AM; Messina C; Mori PG; Miniero R; Colella R; Basso G
J Clin Oncol; 1995 Oct; 13(10):2497-502. PubMed ID: 7595699
[TBL] [Abstract][Full Text] [Related]
3. Treatment of childhood acute lymphoblastic leukemia. Long-term results of the AIEOP-ALL 87 study.
Paolucci G; Vecchi V; Favre C; Miniero R; Madon E; Pession A; Rondelli R; De Rossi G; Lo Nigro L; Porta F; Santoro N; Indolfi P; Basso G; Conter V; Aricò M;
Haematologica; 2001 May; 86(5):478-84. PubMed ID: 11410410
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of the present and previously used protocol of risk stratification in children with acute lymphoblastic leukemia].
Glodkowska E; Bialas A; Jackowska T
Med Wieku Rozwoj; 2007; 11(2 Pt 1):153-8. PubMed ID: 17625285
[TBL] [Abstract][Full Text] [Related]
5. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
[TBL] [Abstract][Full Text] [Related]
6. Mitoxantrone and intermediate-dose cytosine arabinoside for poor-risk acute leukemias: response to treatment and factors influencing outcome.
Sierra J; Grañena A; Bosch F; Carreras E; Martí JM; Urbano-Ispizua A; Rovira M; Rozman C
Hematol Oncol; 1992; 10(6):301-9. PubMed ID: 1296931
[TBL] [Abstract][Full Text] [Related]
7. 6-mercaptopurine dosage and pharmacokinetics influence the degree of bone marrow toxicity following high-dose methotrexate in children with acute lymphoblastic leukemia.
Schmiegelow K; Bretton-Meyer U
Leukemia; 2001 Jan; 15(1):74-9. PubMed ID: 11243403
[TBL] [Abstract][Full Text] [Related]
8. Changes in the nutritional status of nine vitamins in patients with esophageal cancer during chemotherapy.
Liang LQ; Meng LL; Cai BN; Cui ZP; Ma N; Du LH; Yu W; Qu BL; Feng SQ; Liu F
World J Gastroenterol; 2021 May; 27(19):2366-2375. PubMed ID: 34040328
[TBL] [Abstract][Full Text] [Related]
9. Erythrocyte concentrations of B1, B2, B6 but not plasma C and E are reliable indicators of nutrition status in the presence of systemic inflammation.
Ghashut RA; McMillan DC; Kinsella J; Talwar D
Clin Nutr ESPEN; 2017 Feb; 17():54-62. PubMed ID: 28361748
[TBL] [Abstract][Full Text] [Related]
10. Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial.
Vora A; Goulden N; Mitchell C; Hancock J; Hough R; Rowntree C; Moorman AV; Wade R
Lancet Oncol; 2014 Jul; 15(8):809-18. PubMed ID: 24924991
[TBL] [Abstract][Full Text] [Related]
11. [Intracellular retention of cytarabine-triphosphate (Ara-CTP) in blasts of children with acute lymphoblastic leukemia. Correlation with clinical course parameters].
Schiller M; Hohenlöchter B; Schulze-Westhoff P; Zimmermann M; Ritter J; Jürgens H; Boos J
Klin Padiatr; 1996; 208(4):151-9. PubMed ID: 8926681
[TBL] [Abstract][Full Text] [Related]
12. [High doses of cytosine arabinoside in the treatment of patients with acute relapsing or refractory leukemia].
Lobato-Mendizábal E; Ruiz-Argüelles GJ; Marín-López A
Rev Invest Clin; 1989; 41(2):139-45. PubMed ID: 2675236
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic effects of chemotherapeutic regimens containing pirarubicin on the treatment of high-risk or refractory and relapsed acute leukemia in adults].
Li QH; DU X; Huang ZL; Luo CW; Zhong LY; Lin W
Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1195-7. PubMed ID: 16029595
[TBL] [Abstract][Full Text] [Related]
14. PROGNOSIS OF ACUTE LEUKEMIA DEPENDING ON THE IRON METABOLISM PARAMETERS IN CHILDREN AFTER CHORNOBYL NUCLEAR POWER PLANT ACCIDENT.
Bebeshko VG; Bruslova KM; Lyashenko LO; Tsvietkova NM; Gonchar LO; Galkina SG; Zaitseva AL; Reznikova LS; Iatsemyrskii SM; Tsvet LO
Probl Radiac Med Radiobiol; 2020 Dec; 25():390-401. PubMed ID: 33361849
[TBL] [Abstract][Full Text] [Related]
15. Reduced intensity of early intensification does not increase the risk of relapse in children with standard risk acute lymphoblastic leukemia - a multi-centric clinical study of GD-2008-ALL protocol.
Li XY; Li JQ; Luo XQ; Wu XD; Sun X; Xu HG; Li CG; Liu RY; Sun XF; Chen HQ; Lin YD; Li CK; Fang JP
BMC Cancer; 2021 Jan; 21(1):59. PubMed ID: 33435902
[TBL] [Abstract][Full Text] [Related]
16. High-dose methotrexate improves clinical outcome in children with acute lymphoblastic leukemia: St. Jude Total Therapy Study X.
Abromowitch M; Ochs J; Pui CH; Kalwinsky D; Rivera GK; Fairclough D; Look AT; Hustu HO; Murphy SB; Evans WE
Med Pediatr Oncol; 1988; 16(5):297-303. PubMed ID: 3054451
[TBL] [Abstract][Full Text] [Related]
17. Folic acid supplements in vitamin tablets: a determinant of hematological drug tolerance in maintenance therapy of childhood acute lymphoblastic leukemia.
Schrøder H; Clausen N; Ostergård E; Pressler T
Pediatr Hematol Oncol; 1986; 3(3):241-7. PubMed ID: 3153236
[TBL] [Abstract][Full Text] [Related]
18. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
[TBL] [Abstract][Full Text] [Related]
19. Dose intensification of methotrexate and cytarabine during intensified continuation chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: POG 9406: a report from the Children's Oncology Group.
Tower RL; Jones TL; Camitta BM; Asselin BL; Bell BA; Chauvenet A; Devidas M; Halperin EC; Pullen J; Shuster JJ; Winick N; Kurtzberg J
J Pediatr Hematol Oncol; 2014 Jul; 36(5):353-61. PubMed ID: 24608079
[TBL] [Abstract][Full Text] [Related]
20. [Expression of homeobox gene HOXA9 in childhood acute leukemia, and its clinical significance].
Jia XH; Zhu LP; Li JC; Wang CC
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):268-72. PubMed ID: 23607948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
